Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Competitor Analysis: Her2 Receptor Antagonists

Published by: La Merie S.L.

Published: Sep. 1, 2009 - 36 Pages


Table of Contents


Index

Therapeutic Her2 Vaccines

Herceptin Pipeline

Selective Her2 Receptor Antagonists

Dual EGF-R and Her2 Receptor Antagonists

Other Dual Target Her2 Receptor Antagonists

Pan-Her Receptor Antagonists

Multi-Target Her2 Receptor Antagonists

Corporate Her2 Receptor Antagonist R&D Pipelines

About La Merie

Abstract

The present Competitive Intelligence Report about Her2 receptor antagonists provides a competitor evaluation in the field of Her2 (ErbB2) receptor targeting molecules for treatment of cancer as of September 2009.

Targeted treatment of Her2-positive breast cancer with the anti-Her2 antibody trastuzumab has become an example of successful personalized medicine. The commercial success of Herceptin (trastuzumab) with 2008 sales US$ 4.8 bln and the development of resistance to trastuzumab treatment has spurred the discovery and development of efficacy enhanced versions of anti-Her2 antibodies or antibodies binding to an epitope different from that of trastuzumab. Other approaches include the development of therapeutic vaccines to specifically stimulate the immune system against Her2 positive cancer cells. Her2 receptor tyrosine kinase inhibitors with a broader target profile including other members of the Her receptor family or including other targets are also in development. More than 20 new molecular entities targeting Her2 are in clinical development up to phase III including vaccines, cells, proteins, antibodies and small molecules.

The report includes a compilation of current active projects in research and development of molecules targeting the Her2 (ErbB2) receptor. In addition, the report lists company-specific R&D pipelines of Her2 receptor targeting small molecules, antibodies, proteins, cells and vaccines. Competitor projects are listed in a tabular format providing information on:
  • Drug Codes,
  • Target / Mechanism of Action,
  • Class of Compound,
  • Company,
  • Product Category,
  • Indication,
  • R&D Stage and
  • additional comments with a hyperlink leading to the source of information.
Purchase of the pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Access data will be sent by e-mail and allow online work with the project data to print or export an individual report.

Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report

Price and Delivery Options
See related reports or call the number above for help from a research specialist.


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2009